Abstract Objective To determine if multiplex autoantibody arrays can identify novel biomarker signatures in children with one or multiple autoimmune diseases (polyautoimmunity). Methods Plasma collected from children (18 years or younger) in the Boston Children's Hospital Precision Link Biobank for Health Discovery between January 2007 and June 2021 ...
Nan Du +7 more
wiley +1 more source
Diverse phenotypic manifestations of small intestinal mucosa in non-infectious common variable immunodeficiency bowel disease: A case report. [PDF]
He T +8 more
europepmc +1 more source
Gastric antral vascular ectasia: A rare etiology of gastrointestinal bleeding in children
Abstract Gastrointestinal bleeding is relatively common in children. While most patients present with mild bleeding, gastric antral vascular ectasia (GAVE) is a rare but potentially life‐threatening cause. GAVE is typically associated with chronic conditions and more common in adults.
Omar Alharbi +3 more
wiley +1 more source
Common manifestation of common variable immunodeficiency and its diagnostic criteria
González-Granado L
doaj
Granulomatous Brain Involvement in Common Variable Immunodeficiency: A Case Report. [PDF]
Rocha M +4 more
europepmc +1 more source
Crohn’s disease as a debut of common variable immunodeficiency
И. А. Новикова +4 more
openalex +2 more sources
RTA‐408 Enhances Radiosensitivity and Inhibited Tumor Progression via JNK Pathway in Glioblastoma
ABSTRACT Glioblastoma (GBM) is an aggressive brain tumor with poor prognosis owing to its high invasiveness and resistance to therapy. RTA‐408, a synthetic triterpenoid and nuclear factor erythroid 2‐related factor 2 activator, exhibits anti‐inflammatory and anti‐cancer properties; however, its effects on GBM remain unclear. This study investigated the
Hung‐Pei Tsai +6 more
wiley +1 more source
Emergence of Multidrug-Resistant <i>Campylobacter jejuni</i> in a Common Variable Immunodeficiency Patient: Evolution of Resistance Under the Selective Antibiotic Pressure. [PDF]
Juzbašić T +8 more
europepmc +1 more source
ABSTRACT Ibrutinib resistance remains a major obstacle in the treatment of diffuse large B‐cell lymphoma (DLBCL). Fat mass and obesity‐associated protein (FTO) has been implicated in drug resistance through its regulation of N6‐methyladenosine (m6A) modifications; however, whether FTO mediates ibrutinib resistance in DLBCL remains unclear.
Ting‐Ting Lu +5 more
wiley +1 more source

